Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can VR glasses take the sting out of a needle stick?

NCT ID NCT07884682

Symptom relief Sponsor: Erzincan Binali Yildirim Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 20, 2026 · Last updated Oct 21, 2026 · Updated 1 time

Summary

Researchers are testing whether virtual reality glasses can distract adults during peripheral intravenous catheter insertion, the routine placement of a small tube in a vein. The study compares people who wear VR glasses during the procedure with a control group. Participants are adults aged 18 to 65 with no acute or chronic pain and no recent pain medication. The team measures pain, anxiety, oxygen saturation, and pulse rate to see whether the distraction changes how people feel and how their bodies respond.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality glasses used as a distraction during IV insertion
What this could lead to
If it helps, hospitals could offer VR glasses as a simple, drug-free way to ease pain and anxiety during routine needle procedures.
What could go wrong
This is a small, non-randomized study of one procedure in adults, so any benefit may be modest and may not apply to children, other procedures, or different VR setups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

136 people

The number who actually took part.

Started

Mar 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-65 years old, * had no verbal, * perceptual, or visual communication difficulties, * had not taken analgesic medication within the previous 24 hours, * had no fever at admission, * reported no acute or chronic pain, * had no previous history of syncope during PIC insertion Exclusion Criteria: * requested to leave the study, * felt unwell during PIC insertion, * were receiving chemotherapy, * had a previous surgical procedure in the planned insertion area, * had scarring, psoriasis, or active dermatitis at the insertion site, * required more than one attempt for PIC placement, or had undergone an invasive procedure in the same vein within the previous month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Pain VR

Contacts and locations

Locations

  • A Training and Research Hospital

    Erzincan, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.